indications for glp-1 agonists The and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy The expanding role of GLP-1

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes

These medications were specifically engineered to deliver the benefits of GLP-1 continuously, far beyond what your body could achieve naturally

Pemvidutide from Altimmune is another dual GLP-1/glucagon agonist with particular promise for liver disease

It works by producing short-chain fatty acids that stimulate colonic motility

doi: 10.1056/NEJMoa0802743 15 CrabtreeTOgendoJ-JVinogradovaYGordonJIdrisI